Pharmacological Manipulation of Biliary Water and Lipids: Potential Consequences for Prevention of Acute Biliary Pancreatitis

Venneman, Niels G.; vanBerge-Henegouwen, Gerard P.; van Erpecum, Karel J.
June 2005
Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Jun2005, Vol. 5 Issue 2, p193
Academic Journal
Acute biliary pancreatitis, caused by macroscopic cholesterol gallstones or microlithiasis, is often a severe disease with considerable morbidity and mortality. Formation of cholesterol gallstones and microlithiasis is caused by cholesterol crystallization from cholesterol supersaturated gallbladder bile. Particularly patients with fast and extensive crystallization, due to highly concentrated bile, low biliary phospholipid contents and gallbladder mucin hypersecretion seem at risk for pancreatitis. Patients who suffered from acute biliary pancreatitis should undergo cholecystectomy as secondary prevention strategy. For patients at high surgical risk, endoscopic sphincterotomy may be an appropriate alternative. Pharmacological manipulation of biliary lipids by the hydrophilic bile salt ursodeoxycholic acid is reserved for patients with recurrent pancreatitis despite previous cholecystectomy or sphincterotomy, or with contraindications to surgical and endoscopic treatment. Maintenance therapy with ursodeoxycholic acid is however a very effective secondary prevention strategy. Potentially, secondary prevention of acute biliary pancreatitis could also be achieved through decreasing biliary mucin contents by UDCA, NSAIDs or N-acetylcystein, or through achieving bile dilution (currently not feasible).


Related Articles

  • Simplified criteria for predicting the severity of gallstone pancreatitis. K. Singh; Nain, P. S.; Matta, H.; Ohri, A.; Chaudhry, A.; Jam, M. // Indian Journal of Surgery;Jun2005, Vol. 67 Issue 3, p135 

    Background: There was a need for a simple method of predicting the severity of gallstone pancreatitis soon after admission, to guide the clinician for intensive monitoring, or for transfer to a specialist center. Aim: To validate the role of simplified criteria [white blood cell count (WBC)...

  • Thermal analysis and microscopical characterization of cholesterol in gallstones. Kaloustian, J.; De La Porte, Paulette Lechene; El-Moselhy, T.; Lafont, H.; Portugal, H. // Journal of Thermal Analysis & Calorimetry;Nov2005, Vol. 82 Issue 2, p331 

    Cholesterol constitutes the major component of most gallstones. It was identified and determined in gallstones by thermal analysis technique (DSC and TG-DTA), mainly by the use of the melting temperature ( T onset=145°C and T max=149°C) and by DTG peak decomposition ( T max=364°C)....

  • The Genetic Background of Cholesterol Gallstone Formation: An Inventory of Human Lithogenic Genes. Lammert, Frank; Matern, Siegfried // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Jun2005, Vol. 5 Issue 2, p163 

    Family and twin studies as well as animal studies indicate that gallstone disease is, in part, genetically determined. Recently new single gene defects have been identified in specific patients with cholesterol and pigment gallstones. Examples include low phospholipid-associated cholelithiasis...

  • Contribution of Canalicular Glutathione Efflux to Bile Formation. From Cholestasis Associated Alterations to Pharmacological Intervention to Modify Bile Flow. Grattagliano, Ignazio; Portincasa, Piero; Palmieri, Vincenzo O.; Palasciano, Giuseppe // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Jun2005, Vol. 5 Issue 2, p153 

    At least one third of the bile flow is driven osmotically by the amount of hepatic glutathione excreted into canalicular spaces. Beyond the importance of this secretory mechanism for bile formation, the excretion of glutathione is an important way to discharge toxic anionic compounds deriving...

  • Predisposición genética de la litiasis biliar. Curiellópez, Fátima Belén; Madrigal, Bertha Ruiz; Maldonado, Sonia María Román; Cerda, Arturo Panduro // Investigación en Salud;mar2005 Special, Issue 7, p79 

    Gallstone disease (GSD) affects 14% of Mexican population. Family studies suggest that genetics plays an important role, so that research has been conducted to find the association between specific gene polymorphisms and GSD. In western countries, cholesterol gallstones are more prevalent than...

  • Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene. Rosmorduc, Olivier; Poupon, Raoul // Orphanet Journal of Rare Diseases;2007, Vol. 2, p1 

    Low phospholipid-associated cholelithiasis (LPAC) is characterized by the association of ABCB4 mutations and low biliary phospholipid concentration with symptomatic and recurring cholelithiasis. This syndrome is infrequent and corresponds to a peculiar small subgroup of patients with symptomatic...

  • Is It Possible to Predict the Clinical Course of Gallstone Disease? Usefulness of Gallbladder Motility Evaluation in a Clinical Setting. Colecchia, Antonio; Sandri, Lorenza; Bacchi-Reggiani, Maria Letizia; Portincasa, Piero; Palasciano, Giuseppe; Mazzella, Giuseppe; Roda, Enrico; Festi, Davide // American Journal of Gastroenterology;Nov2006, Vol. 101 Issue 11, p2576 

    OBJECTIVE: A knowledge of the predictive factors of the development and persistence of symptoms in gallstone patients (GS) plays a key role in clinical decision making. The aim of this study was to evaluate the presence of predictive factors for biliary pain development in GS, stressing the role...

  • CHRONIC AND ACUTE CHOLECYSTITIS AND COMMON DUCT STONE. Glenn, Frank // American Journal of Gastroenterology;Sep1965, Vol. 44 Issue 3, p232 

    Provides information on a study on chronic and acute cholecystitis and common duct stone presented before the Course in Postgraduate Gastroenterology of the American College of Gastroenterology in New York City from October 22 to 24, 1964. Stages of the disease; Clinical manifestations of acute...

  • Medical therapy will play larger role in stone disease. Overmyer, Mac // Urology Times;5/15/2005, Vol. 33 Issue 6, p1 

    Reports on the medical therapies developed for the treatment of stone disease. Medical and dietary programs established to prevent nephrolithiasis; Advances in endoscopic equipment development to facilitate the minimally invasive removal of stones; Technological advances in Shockwave lithotripsy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics